UTI

SEC source: 0001261654-21-000008 · wf-form4_161057613551220.xml · nonDerivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,848

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000006 · wf-form4_161057603027375.xml · derivative · entry 4

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,582

Underlying: Common Stock, $0.0001 par value · 6,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000006 · wf-form4_161057603027375.xml · nonDerivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,964

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000006 · wf-form4_161057603027375.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000004 · wf-form4_161057581692122.xml · derivative · entry 3

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,087

Underlying: Common Stock, $0.0001 par value · 3,848 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000004 · wf-form4_161057581692122.xml · nonDerivative · entry 2

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,980

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000004 · wf-form4_161057581692122.xml · nonDerivative · entry 1

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-21-000002 · wf-form4_161057565227326.xml · derivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,959

Underlying: Common Stock, $0.0001 par value · 23,569 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

F4 · derivative.expiration_date: The restricted stock units vest in three equal annual installments beginning on 1/7/2021.

SEC source: 0001261654-21-000002 · wf-form4_161057565227326.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,893

F3 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 1/7/2020.

SEC source: 0001261654-21-000002 · wf-form4_161057565227326.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of Common Stock received from vesting of restricted stock units granted on 1/7/2020.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · derivative · entry 12

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Cash · 44,063 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the third anniversary of the grant date at the end of the performance period. The amount delivered is equal to 141% performance achievement pursuant to the terms of the award.

F9 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the third anniversary of the grant date at the end of the performance period. The amount delivered is equal to 141% performance achievement pursuant to the terms of the award.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · derivative · entry 11

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.0001 par value · 13,037 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, which vests based on the 3-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to 141% performance achievement pursuant to the terms of the award.

F8 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, which vests based on the 3-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to 141% performance achievement pursuant to the terms of the award.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · derivative · entry 10

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.0001 par value · 12,328 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Vesting of restricted stock units granted on 12/5/2017.

F7 · derivative.exercise_date: Vesting of restricted stock units granted on 12/5/2017.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · nonDerivative · entry 6

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,871

F3 · balance_after: Performance cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · nonDerivative · entry 5

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Performance cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · nonDerivative · entry 4

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,871

F2 · shares: Shares withheld to satisfy tax liability for the vesting of performance units granted on 12/5/2017.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · nonDerivative · entry 3

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · nonDerivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,629

F1 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/5/2017.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,038

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 11

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Performance Cash · 52,875 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the third anniversary of the grant date at the end of the performance period. The amount delivered is equal to 141% performance achievement pursuant to the terms of the award.

F9 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the third anniversary of the grant date at the end of the performance period. The amount delivered is equal to 141% performance achievement pursuant to the terms of the award.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 10

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.0001 par value · 26,072 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, which vests based on the 3-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to 141% performance achievement pursuant to the terms of the award.

F8 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, which vests based on the 3-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number of shares delivered is equal to 141% performance achievement pursuant to the terms of the award.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 9

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.0001 par value · 14,793 shares

Expires 2020-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Vesting of restricted stock units granted on 12/5/2017.

F7 · derivative.exercise_date: Vesting of restricted stock units granted on 12/5/2017.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 6

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,213

F3 · balance_after: Performance cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 5

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,213

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Performance cash is settled solely in cash upon vesting. Therefore, the amount of securities beneficially owned following the reported transaction did not change.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 4

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,213

F2 · shares: Shares withheld to satisfy tax liability for the vesting of performance units granted on 12/5/2017.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 3

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 2

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,105

F1 · shares: Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/5/2017.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261654-20-000073 · wf-form4_160798828018899.xml · derivative · entry 2

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,754

Underlying: Common Stock, $0.0001 par value · 21,778 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000073 · wf-form4_160798828018899.xml · derivative · entry 1

Kevane Christopher E. · CIK 0001486632 · SVP Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,539

Underlying: Common Stock, $0.0001 par value · 40,834 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000089 · wf-form4_160798980120575.xml · derivative · entry 2

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,437

Underlying: Common Stock, $0.0001 par value · 30,772 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000089 · wf-form4_160798980120575.xml · derivative · entry 1

Anderson Troy R · CIK 0001789633 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,214

Underlying: Common Stock, $0.0001 par value · 54,717 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · derivative · entry 9

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,323

Underlying: Common Stock, $0.0001 par value · 42,501 shares

Expires 2023-12-10

F6 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F6 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000087 · wf-form4_160798967121473.xml · derivative · entry 8

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,594

Underlying: Common Stock, $0.0001 par value · 23,556 shares

Expires 2023-12-10

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F5 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 8

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,769

Underlying: Common Stock, $0.0001 par value · 179,661 shares

Expires 2023-12-10

F6 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F6 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000085 · wf-form4_160798952491911.xml · derivative · entry 7

Grant Jerome Alan · CIK 0001723537 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,528

Underlying: Common Stock, $0.0001 par value · 95,819 shares

Expires 2023-12-10

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F5 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000083 · wf-form4_160798920766941.xml · derivative · entry 2

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,182

Underlying: Common Stock, $0.0001 par value · 15,637 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000083 · wf-form4_160798920766941.xml · derivative · entry 1

Hitchcock Todd A · CIK 0001799015 · SVP Chief Strategy & Transform

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,781

Underlying: Common Stock, $0.0001 par value · 26,134 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000081 · wf-form4_160798906434300.xml · derivative · entry 2

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,694

Underlying: Common Stock, $0.0001 par value · 13,938 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000081 · wf-form4_160798906434300.xml · derivative · entry 1

Mason Sonia Claire · CIK 0001821986 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,927

Underlying: Common Stock, $0.0001 par value · 26,134 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000079 · wf-form4_160798892018364.xml · derivative · entry 3

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,483

Underlying: Common Stock, $0.0001 par value · 13,938 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000079 · wf-form4_160798892018364.xml · derivative · entry 2

Smith Lori B · CIK 0001799017 · SVP Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,781

Underlying: Common Stock, $0.0001 par value · 26,134 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000077 · wf-form4_160798860895182.xml · derivative · entry 2

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,935

Underlying: Common Stock, $0.0001 par value · 15,245 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000077 · wf-form4_160798860895182.xml · derivative · entry 1

Severson Eric · CIK 0001746556 · SVP Admissions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,781

Underlying: Common Stock, $0.0001 par value · 26,134 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000075 · wf-form4_160798845335007.xml · derivative · entry 2

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,270

Underlying: Common Stock, $0.0001 par value · 13,938 shares

Expires 2023-12-10

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal annual installments beginning on December 10, 2021.

SEC source: 0001261654-20-000075 · wf-form4_160798845335007.xml · derivative · entry 1

Fesperman Bart · CIK 0001821616 · SVP Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,382

Underlying: Common Stock, $0.0001 par value · 26,134 shares

Expires 2023-12-10

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2023 and 40% of which vest based on income (loss) from operations for the fiscal year ending September 30, 2023, the sum of which will be adjusted by a compound annual total shareholder return ("TSR") modifier (which modifier may result in the adjustment of the performance units by up to 25% either upward or downward). For purposes of determining the TSR, the change in the price of the UTI Common Stock is based upon the 30-trading day average closing stock price (i) ending on and including the grant date, and (ii) ending on and including the last day of the Performance Period. The amount represents the maximum number of shares that may be delivered pursuant to the award, which is 187.5% of the target number of shares.

SEC source: 0001261654-20-000061 · wf-form4_160098008958292.xml · nonDerivative · entry 2

MCWATERS KIMBERLY J · CIK 0001272480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,461

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F3 · price: The shares were sold at prices ranging from $5.94 to $6.16. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261654-20-000061 · wf-form4_160098008958292.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,823

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F2 · price: The shares were sold at prices ranging from $6.06 to $6.47. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261654-20-000059 · wf-form4_160081008638976.xml · nonDerivative · entry 2

MCWATERS KIMBERLY J · CIK 0001272480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,823

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F3 · price: The shares were sold at prices ranging from $6.315 to $6.550. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261654-20-000059 · wf-form4_160081008638976.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,823

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F2 · price: The shares were sold at prices ranging from $6.50 to $6.70. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.